Shandong Key Laboratory of Clinical Applied Pharmacology, Department of Pharmacy, Affiliated Hospital of Weifang Medical University, Weifang 261041, Shandong Province, China; Clinical Research Center, Affiliated Hospital of Weifang Medical University, Weifang 261041, Shandong Province, China.
School of Pharmacy, Weifang Medical University, Weifang 261053, Shandong Province, China.
Int J Biol Macromol. 2022 Nov 30;221:679-690. doi: 10.1016/j.ijbiomac.2022.09.042. Epub 2022 Sep 9.
In this study, we tested the inhibitory activity of 45 natural products extracted from the plant Toona sinensis on SHP2 protein, and identified four natural product inhibitors. The natural product 1,2,3,6-Tetragalloylglucose (A-1) was first reported as a competitive inhibitor of SHP2, with an IC value of 0.20 ± 0.029 μM and the selectivity of 1.8-fold and 4.35-fold to high homologous proteins SHP1 and PTP1B, respectively. Compound A-1 also showed high inhibitory activity on SHP2-E76K and SHP2-E76A mutants, with IC values of 0.95 ± 0.21 μM and 0.29 ± 0.045 μM, respectively. Cell viability assay showed that compound A-1 could inhibit the proliferation of a variety of cancer cells. Apoptosis assay showed that compound A-1 could effectively induce apoptosis of KRAS-mut NCI-H23 and KRAS-mut A549 cells. Western blot assay showed that compound A-1 could down regulate the phosphorylation levels of Erk1/2 and Akt in NCI-H23 and A549 cells. Molecular docking showed that compound A-1 could effectively dock to the catalytic active region of SHP2. Molecular dynamics simulation explored the effect of compound A-1 on SHP2, revealing the deep-seated binding mechanism. This study would provide valuable clues for the development of SHP2 and its mutant inhibitors.
在这项研究中,我们测试了 45 种从香椿植物中提取的天然产物对 SHP2 蛋白的抑制活性,并鉴定出了四种天然产物抑制剂。天然产物 1,2,3,6-四没食子酰葡萄糖(A-1)首次被报道为 SHP2 的竞争性抑制剂,其 IC 值为 0.20±0.029μM,对高同源蛋白 SHP1 和 PTP1B 的选择性分别为 1.8 倍和 4.35 倍。化合物 A-1 对 SHP2-E76K 和 SHP2-E76A 突变体也表现出高抑制活性,IC 值分别为 0.95±0.21μM 和 0.29±0.045μM。细胞活力测定表明,化合物 A-1 能够抑制多种癌细胞的增殖。凋亡测定表明,化合物 A-1 能够有效诱导 KRAS-mut NCI-H23 和 KRAS-mut A549 细胞凋亡。Western blot 测定表明,化合物 A-1 能够下调 NCI-H23 和 A549 细胞中 Erk1/2 和 Akt 的磷酸化水平。分子对接表明,化合物 A-1 能够有效地对接 SHP2 的催化活性区域。分子动力学模拟探索了化合物 A-1 对 SHP2 的影响,揭示了其深层次的结合机制。这项研究为 SHP2 及其突变体抑制剂的开发提供了有价值的线索。